Shell and CNOOC Expanding Huizhou Complex

Shell Nanhai, Chinese subsidiary of the multinational oil and petrochemicals group, and China National Offshore Oil Corporation (CNOOC) have signed a Heads of Agreement (HOA) to expand their 50:50 joint venture at Huizhou in China’s Guangdong Province.

Under the pact, which is still subject to approvals, Shell will step into its Chinese partner’s ongoing project, which calls for construction of new chemical facilities next to the partnership’s existing Nanhai petrochemical complex.

Plans include an ethylene cracker and ethylene derivatives units, including a styrene monomer and propylene oxide (SMPO/PDO) plant. The new cracker will double Nanhai’s ethylene production capacity by over 1 million t/y to around 2 million t/y. Commercial production from the new facilities is expected in about two years.

The Huizhou site converts a variety of liquid feedstocks into ethylene and derivative products, for use in a wide range of consumer goods, including computers, plastic bottles, and washing liquids. Shell said it will supply its proprietary OMEGA and SMPO/POD technologies to produce ethylene oxide and ethylene glycol, increasing volumes and range of Nanhai’s products, as well as enhancing overall energy efficiency.

Yang Hua, chairman of CNOOC, said the expansion of the Nanhai complex supports the Chinese group’s long-term petrochemicals strategy, and Shell CEO Ben van Beurden said the agreement with its Chinese partner demonstrates the multinational group’s confidence in the strong growth potential for chemicals in China, where it has been active for a century.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read